Go to Main Content

 

 

HELP | EXIT

Common Course Numbering System

 

Your current Institution is CCCS
Transparent Image

 Searching Current Courses For Fall 2016

  Course: PAP 225
  Title:Pharmacology II
  Long Title:
  Course Description:Applies the principles of pharmacology to the prevention and treatment of specific human disorders. Special emphasis is placed on the safe and appropriate use of medications.
  Min Credit:3
  Max Credit:

  Course Notes: Previously PAP 231; made revisions 7/28/09 s@
  Origin Notes: RRCC
  Status Notes: corresponds to 37.5 contact hours
   S: For the Physician Assistant Program, 1 hour credit
  General Notes:revised-crdts,dscrptn,cmptncs 3/5/13

 STANDARD COMPETENCIES:
 
 1. Describe an appropriate stepwise approach to drug therapy for the management of asthma.
 2. Use beta-receptor selectivity and duration of action differences to select a beta-agonist bronchodilator.
 3. Describe the appropriate technique for administration of metered dose inhalers.
 4. Describe the mechanism of action of cromolyn sodium, corticosteroids, theophylline, zafirlukast, zileuton, montelukast, and ipratropium in the treatment of asthma.
 5. Describe the role in asthma treatment of IV steroids, oral steroids, and inhaled steroids.
 6. Identify the side effects of corticosteroids and describe the taper of their use.
 7. List the target serum level for theophylline.
 8. List selected theophylline drug interactions and side effects.
 9. List medications to be avoided in patients with asthma.
 10. Identify the types of hormonal contraceptives available.
 11. Describe the advantages and disadvantages for combination oral contraceptives and progestin only contraceptive products.
 12. Choose appropriate oral contraceptive therapy, if it is indicated
 13. List common adverse effects of the oral contraceptives and describe a management strategy for these adverse effects.
 14. Name at least three drug interactions that occur with hormonal contraceptives and tell how to manage them.
 15. Describe emergency contraception and list several options for emergency contraception.
 16. Describe the benefits of hormone replacement therapy in menopause.
 17. List the risks of hormone replacement therapy.
 18. Choose an appropriate hormone replacement product for a woman in menopause.
 19. Describe the mechanism of action of the various products used to prevent osteoporosis in the post-menopausal woman.
 20. List the advantages and disadvantages of hormone replacement therapy, biphosphonate therapy and selective estrogen receptor modulator therapy in the prevention of post-menopausal osteoporosis.


 I. Allergic Reactions
  A.        Hypersensitivity
  B.        Treatment
  1.        First- and second-generation antihistamines
  2.        Decongestants
  3.        Intranasal corticosteroids
  4.        Intranasal cromolyn
  II.       Peripheral Nervous System
  A.        Sympathetic
  1.        Parasympathetic
  B.        Cholinergic
  1.        Adrenergic
  a)        Sympathomimetics
  III.      Analgesics
  A.        Local Anesthetics
  B.        Pain / Inflammation
  C.        Narcotics
  D.        NSAIDs
  IV.      Psychotropic
  A.        Serotonin Blockers / Agonists
  B.        Tricyclics
  C.        Oncology / Pain Management
  D.        Depression
  E.        Anxiety
  F.        Schizophrenia
  G.        Eating Disorders
  H.        Obsessive / Compulsive
  I.         Sleep Disorders
  J.        Alcohol
  K.        Seizures
  L.        Migraines
  M.       Geriatrics (Alzheimer’s, Parkinson’s)
  V.       Infectious Disease
  A.        Antibiotics
  B.        Viral
  C.        Protozoal
  D.        Fungal
  E.        Antimicrobial Therapy in Pregnancy
  VI.      HIV
  A.        Protease Inhibitors
  B.        Reverse Transcriptase
  C.        Antimicrobial Therapy in Prophylaxis
  VII.     Renal
  A.        Dosage Adjustment
  B.        Gout
  C.        Edema
  D.        Effects of Dialysis
  E.        Drug-induced Renal Diuretics
  F.        Diuretics
  G.        Uricosurics
  H.        Potassium
  VIII.   Pulmonary
  A.        Asthma
  B.        COPD
  C.        Emphysema
  D.        Cough and Cold
  E.        Beta-agonists
  F.        Corticosteroids
  G.        Mast Cell Stabilizers
  H.        Methylxanthines
  IX.      Gastrointestinal
  A.        Diarrhea
  B.        Constipation
  C.        GERD
  D.        Peptic / Duodenal Ulcers
  E.        Antacids
  F.        Blockers
  G.       Proton Pumps
  H.       Prokinetic Drugs
  I.        Anti-emetics
  J.        Prostaglandins
  X.       Female
  A.        Reproductive
  B.        Pregnancy
  C.        STDs
  D.        Hormone Replacement Therapy
  E.        Osteoporosis
  F.        Over-the-Counter
  XI.      Male
  A.        Prostate
  B.        Erectile Dysfunction
  XII.     Endocrine
  A.        Thyroid
  B.        Diabetes
  C.        Corticosteroids
  D.        Insulin
  E.        Glucogen
  F.        Sulfonylureas
  G.        Glucosidage Inhibitors
  H.        Thyroid Replacement
  XIII.    Nervous System
  A.        Transient Ischemic Attacks
  B.        Multiple Sclerosis
  XIV.    Musculoskeletal
  A.        Muscle Relaxants
  B.        Incontinence
 


Transparent Image
Skip to top of page

Skip CCNS Pub Presentation Links

[ CCNS Main Menu ]

Release: 8.5.3